Track topics on Twitter Track topics that are important to you
Today's Daily Dose brings you news about Alkermes' curious reversal of event; outcome of Apricus' end-of-review meeting with the FDA related to Vitaros; FDA approval of Bristol-Myers Squibb Co.'s Immuno-Oncology combination therapy, and Merck's KEYNOTE-189 study.
Original Article: ALKS Pulls Off Sweet Surprise, APRI Thrashed, BMY Gets FDA NodNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...